BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35662447)

  • 1. Novel Therapeutics and Treatment Strategies for Medullary Thyroid Cancer.
    Walgama E; Busaidy N; Zafereo M
    Endocrinol Metab Clin North Am; 2022 Jun; 51(2):379-389. PubMed ID: 35662447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical Treatment of Medullary Thyroid Cancer.
    Machens A; Dralle H
    Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Endocrine Neoplasia Type 2B Associated Mixed Medullary and Follicular Thyroid Carcinoma in A Chinese Patient with RET M918T Germline Mutation.
    Qi XP; Lin GB; Chen B; Li F; Cao ZL; Zheng WH; Zhao JQ
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):554-560. PubMed ID: 32660411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical and clinical strategies in the management of thyroid medullary carcinoma in children with and without ret proto-oncogene mutations.
    Boybeyi-Türer Ö; Vurallı D; Karnak İ; Gönç N; Yalçın EŞ; Orhan D; Kandemir N; Tanyel FC
    Turk J Pediatr; 2016; 58(4):436-441. PubMed ID: 28276221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding and management of medullary thyroid cancer.
    Roy M; Chen H; Sippel RS
    Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of medullary thyroid carcinoma with de novo V804M RET germline mutation.
    Choi YS; Kwon HJ; Kim BK; Kwon SK; Park YH; Kim JH; Jung SB; Lee CH; Lee SK; Uchino S
    J Korean Med Sci; 2013 Jan; 28(1):156-9. PubMed ID: 23341727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
    Matrone A; Gambale C; Prete A; Elisei R
    Front Endocrinol (Lausanne); 2022; 13():864253. PubMed ID: 35422765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment.
    Dabelić N; Jukić T; Fröbe A
    Acta Clin Croat; 2020 Jun; 59(Suppl 1):50-59. PubMed ID: 34219884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RET Proto-oncogene Gene Mutation Is Related to Cervical Lymph Node Metastasis in Medullary Thyroid Carcinoma.
    Wang S; Wang B; Xie C; Ye D
    Endocr Pathol; 2019 Dec; 30(4):297-304. PubMed ID: 31494787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic treatment and management approaches for medullary thyroid cancer.
    Ernani V; Kumar M; Chen AY; Owonikoko TK
    Cancer Treat Rev; 2016 Nov; 50():89-98. PubMed ID: 27664392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
    Barletta JA; Nosé V; Sadow PM
    Endocr Pathol; 2021 Mar; 32(1):35-43. PubMed ID: 33492588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.
    Pelizzo MR; Torresan F; Boschin IM; Nacamulli D; Pennelli G; Barollo S; Rubello D; Mian C
    Am J Clin Oncol; 2015 Oct; 38(5):508-13. PubMed ID: 24064755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
    Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET gene mutation analysis and long-term clinical outcomes of medullary thyroid cancer patients.
    Prabhu M; Shakya S; Ballal S; Ahmed Shamim S; Bal C
    Nucl Med Commun; 2020 Nov; 41(11):1136-1142. PubMed ID: 32796450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
    Jozaghi Y; Zafereo M; Williams MD; Gule-Monroe MK; Wang J; Grubbs EG; Vaporciyan A; Hu MI; Busaidy N; Dadu R; Waguespack SG; Subbiah V; Cabanillas M
    Head Neck; 2021 Jan; 43(1):E7-E12. PubMed ID: 33169506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.